This page is for clinic review ONLY outside of the EngagedMD platform.
Open
Close
MQL_US_SOL_1_QOL
Managing Side Effects and Quality of Life
RTS_US_SOL_1_Radiation
Radiation Therapy for Advanced Prostate Cancer
CRT_US_SOL_1_Intro
Provenge®: Cellular Immunotherapy for Advanced Prostate Cancer
CRT_US_SOL_2_Treatment
What to Expect During Treatment
AMT_US_SOL_1_Intro
Oral Hormone-Targeted Therapies for Advanced Prostate Cancer
AMT_US_SOL_2_Monitoring
Side Effects and Monitoring
CAP_US_SOL_1_Chemo
Chemotherapy for Advanced Prostate Cancer
CAP_US_SOL_2_Treatment
What To Expect During Treatment
ARPI_US_SOL_1_APRI
APRIs for Advanced Prostate Cancer
ARPI_US_SOL_2_Monitoring
Monitoring and Side Effects
CYP_US_SOL_1_Med
Abiraterone: Oral Hormone-Targeted Therapy for Advanced Prostate Cancer
CYP_US_SOL_2_Monitoring
XOF_US_SOL_1_Intro
Xofigo: Radiopharmaceutical Therapy for Advanced Prostate Cancer
XOF_US_SOL_2_Expect
PLU_US_SOL_1_Intro
Pluvicto: Radiopharmaceutical Therapy for Advanced Prostate Cancer
PLU_US_SOL_2_Risks
ORG_US_SOL_1_About
Orgovyx: Oral Hormone Therapy
ORG_US_SOL_2_Risks
Risks and Side Effects
XTA_US_SOL_1_About
Xtandi for Advanced Prostate Cancer
XTA_US_SOL_2_Risks
ERL_US_SOL_1_About
Erleada for Advanced Prostate Cancer
ERL_US_SOL_2_Risks
NUB_US_SOL_1_About
Nubeqa for Advanced Prostate Cancer
NUB_US_SOL_2_Risks
PBH_US_1_Prosteon
Prosteon: Targeted Bone Support During Prostate Cancer Treatment
MSI_US_SOL_1_MedSafe
Medication Safety
IBC_US_SOL_1_Intro
Bladder Cancer Basics
BCD_US_SOL_1_Pathology
Understanding Your Pathology Report
BCD_US_SOL_2_Treatment
Treatment Options
BCM_US_SOL_1_Surveillance
Bladder Cancer Surveillance
YBT_US_SOL_1_Team
Your Bladder Cancer Team
BCT_US_SOL_1_Intro
Transurethral Resection of Bladder Tumor
BCT_US_SOL_2_Procedure
The Procedure
BCT_US_SOL_3_Recovery
Recovery
BCT_US_SOL_4_Risks
Risks and Complications
BBC_US_SOL_1_Procedure
Bladder Biopsy
BBC_US_SOL_2_Recovery
BBC_US_SOL_3_Risks
BPP_US_SOL_1_About
Trimodal Therapy for Bladder Preservation
MXT_US_SOL_1_Intro
TURBT in Bladder Preservation Therapy
MXT_US_SOL_2_Procedure
MXT_US_SOL_3_Recovery
MXT_US_SOL_4_Risks
RBP_US_SOL_1_Intro
Radiation Therapy for Bladder Cancer
RBP_US_SOL_2_Before
Before Treatment
RBP_US_SOL_3_During
What to Expect During Radiation Therapy
RBP_US_SOL_4_Risks
RBP_US_SOL_5_Treatment
Navigating Treatment
CSP_US_SOL_1_About
Cisplatin Chemotherapy for Bladder Preservation
CSP_US_SOL_2_Risks
SCY_US_SOL_1_Intro
What is a Salvage Cystectomy?
SCY_US_SOL_2_Prep
Preparing for Surgery
SCY_US_SOL_3_Procedure
SCY_US_SOL_4_Recovery
SCY_US_SOL_5_Risks
CTY_US_SOL_1_Intro
Radical Cystectomy
CTY_US_SOL_2_Prep
CTY_US_SOL_3_Procedure
CTY_US_SOL_4_Recovery
CTY_US_SOL_5_Risks
MBO_US_SOL_1_Decision
Choosing Your Treatment: Bladder Preservation vs Bladder Removal
ITB_US_SOL_1_Intro
Intravesical Therapy for Bladder Cancer
ITB_US_SOL_2_Expect
What to Expect
SRS_US_SOL_1_About
Intravesical Therapy: Sustained-Release System
SRS_US_SOL_2_Expect
SSC_US_SOL_1_Stoma
Caring for Your Urinary Stoma
SSC_US_SOL_2_Pouch
Your Pouching System
FUM_US_SOL_1_About
5-FU + Mitomycin C Chemotherapy for Bladder Preservation
FUM_US_SOL_2_Risks
MBP_US_SOL_01_Monitoring
Monitoring After Bladder Preservation Therapy
GCH_US_SOL_1_About
Gemcitabine Chemotherapy for Bladder Preservation
GCH_US_SOL_2_Risks
NLX_US_SOL_1_About
Inlexzo: Intravesical Sustained-Release Gemcitabine
NLX_US_SOL_2_Risks
BCG_US_SOL_1_About
Intravesical BCG Immunotherapy
BCG_US_SOL_2_Risks
GIG_US_SOL_1_About
Intravesical Gemcitabine
GIG_US_SOL_2_Risks
MMC_US_SOL_1_About
Intravesical Mitomycin C
MMC_US_SOL_2_Risks
SIT_US_SOL_1_About
Sequential Intravesical Gemcitabine and Docetaxel
SIT_US_SOL_2_Risks
